Arman Shahriar, MD
@ArmanAShahriar
Followers
414
Following
671
Media
17
Statuses
384
🇺🇸 🇮🇷 🇪🇨∙PGY-3 @MedChiefs∙via @umnmedschool @umnbme @bostonsci ⚽️ enthusiast
Chicago, IL
Joined July 2017
She is the very best. Congrats Newsh!!! @MedChiefs
Incredibly grateful to @AASLDFoundation for selecting me as the Bruce A. Luxon Emerging Liver Scholar Thank you so much to Dr. Sonali Paul and Dr. @doctornikkid for their support Excited to meet everyone and represent @UChicagoGI @MedChiefs at #TLM2025
#GITwitter @AASLDtweets
1
0
3
@ArmanAShahriar @ESC_Journals @adamcifu A pleasure to work with you on this @ArmanAShahriar and @adamcifu, and thanks to @ESC_Journals for publishing!
0
2
3
Very proud of this paper. Kudos to @ArmanAShahriar for doing ALL the heavy lifting. @Jonathan_PaulMD Endovascular management of intermediate-risk pulmonary embolism: evidence, outstanding questions, drivers of utilization, and the horizon
academic.oup.com
Abstract. In patients with acute intermediate-risk pulmonary embolism (PE) guidelines recommend systemic anticoagulation (Class I; Level A), but intermedia
0
3
9
We contextualize key studies (complete + ongoing) and provide plausible explanations for contemporary utilization in the absence of randomized (AC-controlled) evidence.
0
0
1
Just out in @ESC_Journals we (@adamcifu + @Jonathan_PaulMD) review endovascular therapy in intermediate-risk PE. Link: https://t.co/jtLCN1AGOV
2
1
5
This was fun. Residency has been such a blur.
Love this episode. 2nd of a 4 part of series talking to trainees. 1st a student, now a resident, @ArmanAShahriar
@MedChiefs
0
0
3
Congratulations to @MedChiefs resident Dr. Ryan Sachar, and @kychangmd, on their presentation at #AHA24! Patients screening positive for HFpEF with @ultromics AI algorithm had higher PA pressures, c/w more advanced disease
1
1
21
"It is critical to collect detailed social demographic data to identify inequities without otherizing patients into stereotypical aggregate wholes that do not make sense for heterogeneous populations" Well done.
Grateful for the opportunity to write this commentary on Heart Failure data disaggregation with @MarshallChinMD and @BryanSmithMD for JAMA Network Open. https://t.co/XA6MNKWqgt
0
0
5
Dear enemies,The Black Swan is now the most influential (that is, discussed/mentioned) 21st C book. While almost all books have a half-life between 2 and 6 months, it does not appear to have a half-life. #Lindy [Same with other 4 books in the Incerto. Graph is US only]
616
636
8K
I think the field of medicine might improve if we 100% stopped considering research when selecting candidates for med school and residency. Those who love research would keep doing it (good). Those who don't love it would stop doing junk research (also good). Research might go
It's really sad that so many young people who want to go into medicine get tricked into working for pipetting laboratories. Then we make them lie and say they enjoyed the pointless hazing that has nothing to do with clinical medicine.
46
207
2K
PBMs say they don't set drug prices, but their own data disagrees. For example, Medicare data for CVS Health plans show them setting 597 different prices for imatinib that are as low as $2,658 and as high as $8,199. @mcuban sells the same drug for $40. https://t.co/iPL1VkTmzL
8
67
172
I have had at least 5 patients (in residency) who are otherwise either (a) fine or (b) have bigger problems, come to clinic saying they have PAD because apparently managed Medicare knows more about screening than we do
My mother called me in a panic (and how that call helped me understand Medicare Advantage): "Robert, they told me I have bad blood flow in my legs. What do I do?!" Woah. Wait, what? Who told you that?
0
1
2
Amen
Patients who were admitted for a week with sepsis requiring abscess drainage, a fib, and a kidney injury don’t need 12 pages of “heart healthy eating tips” in their discharge paperwork. They need to be able to see their instructions, meds, and appointments simply and clearly.
0
0
2
Our curious @MedChiefs residents came to me, unsolicited, with some thoughts on ENACT-HF that they put into a Letter-to-the-Editor @CircHF Led to a great HF Journal Club on this trial and use of urine-Na. Great work @ArmanAShahriar & @TessAllanMed! https://t.co/DqEzGtNl8p
ahajournals.org
0
1
8
this is so well written
Time for a thread on malignancy in surgical residency, inspired by the current #medtwitter drama which features an anonymous residency review website targeting my residency, @BCMGSRes which I consider one of the best in the country https://t.co/szuRJEYlgq
0
0
3
Insane.
This story is wild. (And unfortunately, something I expect we’ll see more of in the future.)
0
0
3
Rising goat right here @MedChiefs
Honored to represent @UChicagoMed & @MedChiefs at #ACCC24! Huge thanks to Dr. Shah for amazing mentorship.
0
0
4